Skip to main content
Log in

Stimulation of cell proliferation in rabbits by MTP-PE, a lipophilic muramyl peptide

  • Published:
Virchows Archiv B

Summary

The in vivo effect of the lipophilic muramyl peptide MTP-PE on the proliferation of blood cells and various tissues of the rabbit was studied by means of3H-thymidine. Animals were killed up to 120 h after one or two i.v. injections of MTPPE (10 mg/kg). MTP-PE caused a drastic effect on white blood cells: (1) neutropenia and lymphocytopenia occurring within 5 h was followed by leukocytosis of neutrophils and their juvenile forms by 24 h and thereafter, (2) within 24 h the number of prelabelled, i.e. recently regenerated, mononuclear cells in the bone marrow and the vascular system of various tissues increased aproximately threefold, and (3) within 48 h the concentration of proliferating monocytic cells (1-h pulse labelling) rose to maximum levels of up to 20-fold in the lumina of blood vessels, particularly in capillaries of many organs. The number of proliferating cells also increased in the adventitia of medium and small arteries with a maximum at 48 h, whereas this occurred only later in the media and hardly at all in the intima. Thus, these proliferating, apparently monocytic cells are blood derived, and migrate into the tissue within 24 h after MTP-PE administration. In addition, proliferation in the epithelium of the bile ducts and oesophagus was also stimulated with a maximum at 24 h after MTP-PE. In contrast, enhanced proliferation occurred more slowly and to a lesser extent in hepatocytes, hepatic interstitial cells, and renal epithelial cells, consistent with a regenerative process after an inflammatory or toxic event.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Allison AC, Wachsmuth ED (1986) MDP and derivatives II. In: Chedid L, Dukor P, Spreafico F, Willoughby D (eds) Advances in Immunopharmacology 3. Pergamon Press, London, pp 497–485

    Google Scholar 

  • Braun DG, Dukor P, Lukas B, Schumann G, Tarcsay L, Court M, Schaffner JC, Skripsky T, Fischer M, Graepel P (1987) MTP-PE, a synthetic lipophilic muramyltripeptide, biological and toxicological properties. In: Berlin A, Dean J, Draper MH, Smith EMB, Spreafico F (eds) Immunotoxicology. Martinus Nijhoff Publ, Dordrecht, pp 219–233

    Google Scholar 

  • Brownbill AF, Braun DG, Dukor P, Schumann G (1985) Induction of tumouricidal leucocytes by the intranasal application of MTP-PE, a lipophilic muramyl peptide. Cancer Immunol Immunother 20:11–17

    Article  PubMed  CAS  Google Scholar 

  • Chedid L, Audibert F, Johnson AG (1978) Biological activities of muramyl dipeptides, a synthetic glycopeptide analogous to bacterial immunoregulating agents. Proc Allergy 25. Karger, Basel, pp 63–105

    Google Scholar 

  • Court M, Schaffner JC, Skripsky T, Fischer M, Graepel P (1985) Muramyl-tripeptide (MTP-PE): toxicity after intravenous and intranasal administration. Int J Immunopharmacol 7:631

    Article  Google Scholar 

  • Dietrich FM, Lukas B, Schmidtruppin KH (1983) Prophylactic and therapeutic effects of MTP-PE, a synthetic muramyl peptide, in experimental virus infections. Proc of the 13th Int Congress of Chemotherapy 91:50–53

    Google Scholar 

  • Ellouz F, Adam A, Ciorbaru R, Lederer E (1974) Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem Biophys Res Commun 59:1317–1325

    Article  PubMed  CAS  Google Scholar 

  • Fidler IJ, Fogler WE, Tarcsay L, Schumann G, Braun DG, Schroit AJ (1983) Systemic activation of macrophages and treatment of cancer metastases by liposomes containing hydrophilic or lipophilic muramyl dipeptide. In: Hadden JW, Dukor P, Spreafico F, Willoughby D (eds) Advances in immunopharmacology 2. Pergamon Press, London pp 235–241

    Google Scholar 

  • Fidler IJ, Sone S, Fogler WE, Smith D, Braun DG, Tarcsay L, Gisler RH, Schroit AJ (1982) Efficacy of liposomes containing a lipohilic muramyl dipeptide derivative for activating the tumoricidal properties of alveolar macrophages in vivo. J Biol Resp Modif 1:43–55

    CAS  Google Scholar 

  • Gisler RH, Dietrich FM, Baschang G, Brownbill A, Schumann G, Staber FG, Tarcsay L, Wachsmuth ED, Dukor P (1979) New developments in drugs enhancing the immune response: Activation of lymphocytes and accessory cells by muramyl dipeptides. In: Turk JL, Parker D (eds) Drugs and immune responsiveness. McMillan Press Ltd, London, pp 133–160

    Google Scholar 

  • Gisler RH, Schumann G, Sackmann W, Pericin C, Tarcsay L, Dietrich FM (1982) A novel muramyl peptide, MTP-PE: Profile and biological activities. In: Yamamura Y, Kotani S (eds) Immunomodulation by Microbial Products and Related Synthetic Compounds, Excerpta Medica, Amsterdam, pp 167–170

    Google Scholar 

  • Kotani S, Watanabe Y, Kinoshita F, Shimono T, Morisaki I, Shiba T, Kusumoto S, Tarumi Y, Ikenaka K (1975) Immunoadjuvant activities of synthetic N-acetyl-muramylpeptides or amino acids. Biken J 18:105–111

    PubMed  CAS  Google Scholar 

  • Kotani S, Watanabe Y, Shimono T, Harada K, Shiba T, Kusumoto S, Yokogawa K, Taniguchi M (1976) Correlation between the immunoadjuvant activities and pyrogenicities of synthetic N-acetylmuramyl peptides or amino acids. Biken J 19:9–13

    PubMed  CAS  Google Scholar 

  • Lederer E (1980) Immunostimulation: Recent progress in the study of natural and synthetic immunomodulators derived from the bacterial cell wall. In: Fougereau M, Dausset J (eds) Immunology 80. Academic Press, New York, pp 1194–1211

    Google Scholar 

  • Lederer E (1982) Immunomodulation by muramyl peptides: recent developments. Clin Immunol Newslett 3:83–86

    Article  Google Scholar 

  • Merser C, Sinay P, Adam A (1975) Total synthesis and adjuvant activity of bacterial peptidoglycan derivatives. Biochem Biophys Res Commun 66:1316–1322

    Article  PubMed  CAS  Google Scholar 

  • Osada Y, Otani T, Sato M, Une T, Matsumoto K, Ogawa H (1982) Polymorphnuclear leukocyte activation by a synthetic muramyl dipeptide analog. Infect Immun 38:848–854

    PubMed  CAS  Google Scholar 

  • Pabst JJ, Johnston RB jr (1980) Increased production of superoxide anion by macrophages exposed in vitro to muramyl dipeptide or lipopolysaccharide. J Exp Med 151:101–114

    Article  PubMed  CAS  Google Scholar 

  • Wachsmuth ED, Dukor P (1982) Immunopathology of muramyl-peptides. In: Yamamura Y, Kotani S (eds) Immunomodulation by microbial products and related compounds. Excerpta Medica, Amsterdam, pp 60–71

    Google Scholar 

  • Wachsmuth ED, Becker M, Grieve AP, Maurer-Schultze B (1984) Fully automated and fast image analysis of autoradiographs with a TAS-Leitz. Determination of size, Feulgen fluorescence and grain counts of invidual nuclei and their evaluation by a simplified cluster analysis. Histochemistry 81:227–236

    Article  PubMed  CAS  Google Scholar 

  • Wuest B, Wachsmuth ED (1982) Stimulatory effect of N-acetyl muramyl dipeptide in vivo: Proliferation of bone marrow progenitor cells in mice. Infect Immun 37:452–462

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wachsmuth, E.D. Stimulation of cell proliferation in rabbits by MTP-PE, a lipophilic muramyl peptide. Virchows Archiv B Cell Pathol 54, 195–206 (1987). https://doi.org/10.1007/BF02899212

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02899212

Key words

Navigation